Anxiety Disorders And Depression Treatment Market

Future Market Insights

Key Insight

The anxiety disorders and depression treatment market is projected to grow from USD 12.8 billion in 2025 to USD 17.9 billion by 2035, at a CAGR of 3.4%. Antidepressants will dominate with a 47.6% market share, while anxiety will lead the indication segment with a 53.2% share.

August 02, 2025

Anurag Sharma

250 Pages

Cite this Report

Anxiety Disorders And Depression Treatment Market

https://www.futuremarketinsights.com/reports/anxiety-disorders-and-depression-treatment-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
Eli Lilly and Company
GlaxoSmithKline Pharmaceuticals Ltd
Merck KGaA
Novartis

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Anxiety Disorders And Depression Treatment Market

Key Players

Similar Industry Reports